Shennon Biotechnologies Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
Shennon Biotechnologies operates in biotechnology research and has developed a proprietary platform capable of functionally profiling millions of immune cells at the single-cell level with high throughput and accuracy, addressing a bottleneck in immunotherapy. The company analyzes immune cells alongside their antigen targets to inform the development of therapies for solid tumors and autoimmune diseases. It is based in San Francisco, California, near UCSF Mission Bay. Its customers include researchers and teams in immunology and oncology seeking more effective immunotherapies, and the company positions itself within the biotechnology research sector to support therapy discovery and optimization. As a small to mid-sized firm, it focuses on translating single-cell functional profiling into actionable biology to accelerate immunotherapy development.